Fosun Pharma (600196.SH) plans to repurchase its A-shares for RMB 250 million to RMB 500 million.
Zhitong Finance APP News, Fosun Pharma (600196.SH) announced that on November 22, 2026, pursuant to the 2026 A-share repurchase authorization, the Company's 45th meeting of the 10th Board of Directors deliberated and approved the "Proposal on the A-share Repurchase Plan by Way of Centralized Bidding." The total repurchase funds shall be no less than RMB 250 million and no more than RMB 500 million (both inclusive), and the upper limit of the repurchase price range is RMB 33 per share.
Latest

